Caroff, Stanley N.
Roberts, Christopher B.
Rosenberg, Henry
Tobin, Joseph R.
Watt, Stacey
Mashman, Darlene
Riazi, Sheila
Berkowitz, Rosalind M.
Funding for this research was provided by:
Eagle Pharmaceuticals (Not applicable)
Article History
Received: 5 June 2022
Accepted: 9 September 2022
First Online: 19 September 2022
Declarations
:
: All investigations and analyses of human data in this research were performed in accordance with relevant guidelines and regulations of the Declaration of Helsinki. The institutional review board at the Corporal Michael J. Crescenz VA Medical Center approved this project as an exempted study without the need for informed consent.
: Not applicable.
: SNC has received research grants from Neurocrine Biosciences and Eagle Pharmaceuticals and served as a consultant for Neurocrine Biosciences and Adamas Pharmaceuticals. CBR, HR, JT, SW, DM, SR, RMB declare that they have no competing interests.